Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetics to Prevent Lung Injury in Cardiac Surgery
NCT02918877Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sevoflurane in Inflammatory lung injury, ischemia-reperfusion lung injury (LIRI) and postoperative pulmonary complications (PPC) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Bronchoalveolar Lavage Concentration of TNF Alpha. Started Jun 2017; status: completed.
02
Drugs
sevoflurane
03
Conditions
Inflammatory lung injuryischemia-reperfusion lung injury (LIRI)postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT02918877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918877.